An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study

Kota Nakamura, Zhongxu Zhu, Eunsung Jun, +24

Gastroenterology

Tumor BiologyPancreatic CancerMedicinePathologyCancer Genomics +9

A Liquid Biopsy Signature for the Detection of Patients With Early-Onset Colorectal Cancer

Kota Nakamura, Goretti Hernández, Geeta G. Sharma, +13

Gastroenterology

Prognostic BiomarkersLiquid Biopsy SignatureOncologyCancer DetectionMedicine +11

A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases

Satoshi Nishiwada, Masayuki Sho, Jasjit K. Banwait, +5

Gastroenterology

Tumor BiologyPancreatic CancerMedicineLymph Node MetastasesPathology +7

A Comparison Between Plastic and Metallic Biliary Stent Placement in Patients Receiving Preoperative Neoadjuvant Chemoradiotherapy for Resectable Pancreatic Cancer

Kota Nakamura, Masayuki Sho, Takahiro Akahori, +10

World Journal of Surgery

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients with advanced solid tumors

Kohei Shitara, Taroh Satoh, Satoru Iwasa, +12

Journal for ImmunoTherapy of Cancer

Significance of the inflammation-based prognostic score in recurrent pancreatic cancer

Kenji Nakagawa, Masayuki Sho, Takahiro Akahori, +8

Pancreatology

Tumor BiologyPrognostic BiomarkersPancreatic CancerPancreatic Fluid CollectionMedicine +7

Phase II Study of the Triple Combination Chemotherapy of SOXIRI (S-1/Oxaliplatin/Irinotecan) in Patients with Unresectable Pancreatic Ductal Adenocarcinoma

Takahiro Akahori, Masayuki Sho, Hiroaki Yanagimoto, +9

The Oncologist

Safety and pharmacokinetics of quizartinib in Japanese patients with relapsed or refractory acute myeloid leukemia in a phase 1 study

Kensuke Usuki, Hiroshi Handa, Ilseung Choi, +7

International Journal of Hematology

Hematological MalignancyOncologyMedicineMixed-phenotype Acute LeukemiaHematology +7

Prognostic factors for actual long-term survival in the era of multidisciplinary treatment for pancreatic ductal adenocarcinoma

Kenji Nakagawa, Takahiro Akahori, Satoshi Nishiwada, +9

Langenbeck s Archives of Surgery

Prognostic FactorsPrognostic EvaluationSurgical OncologyPancreatic CancerMedicine +7

Transcriptomic Profiling Identifies an Exosomal microRNA Signature for Predicting Recurrence Following Surgery in Patients With Pancreatic Ductal Adenocarcinoma

Satoshi Nishiwada, Ya Cui, Masayuki Sho, +14

Annals of Surgery